377 related articles for article (PubMed ID: 20675406)
1. Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver.
Benhamouche S; Curto M; Saotome I; Gladden AB; Liu CH; Giovannini M; McClatchey AI
Genes Dev; 2010 Aug; 24(16):1718-30. PubMed ID: 20675406
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis type 2/Merlin: sharpening the myth of prometheus.
Drvarov O; Cubero FJ
Hepatology; 2011 May; 53(5):1767-70. PubMed ID: 21520182
[TBL] [Abstract][Full Text] [Related]
3. Molecular alterations of the NF2 gene in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Zhang N; Zhao Z; Long J; Li H; Zhang B; Chen G; Li X; Lv T; Zhang W; Ou X; Xu A; Huang J
Oncol Rep; 2017 Dec; 38(6):3650-3658. PubMed ID: 29130106
[TBL] [Abstract][Full Text] [Related]
4. WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice.
Park J; Kim JS; Nahm JH; Kim SK; Lee DH; Lim DS
Mol Cells; 2020 May; 43(5):491-499. PubMed ID: 32451369
[TBL] [Abstract][Full Text] [Related]
5. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.
Zhang N; Bai H; David KK; Dong J; Zheng Y; Cai J; Giovannini M; Liu P; Anders RA; Pan D
Dev Cell; 2010 Jul; 19(1):27-38. PubMed ID: 20643348
[TBL] [Abstract][Full Text] [Related]
6. Deletion of
Gerardo-Ramírez M; Giam V; Becker D; Groth M; Hartmann N; Morrison H; May-Simera HL; Radsak MP; Marquardt JU; Galle PR; Herrlich P; Straub BK; Hartmann M
Cells; 2023 Apr; 12(9):. PubMed ID: 37174657
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators.
Lavado A; He Y; Paré J; Neale G; Olson EN; Giovannini M; Cao X
Development; 2013 Aug; 140(16):3323-34. PubMed ID: 23863479
[TBL] [Abstract][Full Text] [Related]
8. Merlin, the product of NF2 gene, is associated with aromatase expression and estrogen formation in human liver tissues and liver cancer cells.
Cocciadiferro L; Miceli V; Granata OM; Carruba G
J Steroid Biochem Mol Biol; 2017 Sep; 172():222-230. PubMed ID: 27289045
[TBL] [Abstract][Full Text] [Related]
9. Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development.
Serinagaoglu Y; Paré J; Giovannini M; Cao X
Dev Biol; 2015 Feb; 398(1):97-109. PubMed ID: 25433207
[TBL] [Abstract][Full Text] [Related]
10. Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.
Li W; Cooper J; Zhou L; Yang C; Erdjument-Bromage H; Zagzag D; Snuderl M; Ladanyi M; Hanemann CO; Zhou P; Karajannis MA; Giancotti FG
Cancer Cell; 2014 Jul; 26(1):48-60. PubMed ID: 25026211
[TBL] [Abstract][Full Text] [Related]
11. YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells.
White SM; Avantaggiati ML; Nemazanyy I; Di Poto C; Yang Y; Pende M; Gibney GT; Ressom HW; Field J; Atkins MB; Yi C
Dev Cell; 2019 May; 49(3):425-443.e9. PubMed ID: 31063758
[TBL] [Abstract][Full Text] [Related]
12. β1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin.
Sabra H; Brunner M; Mandati V; Wehrle-Haller B; Lallemand D; Ribba AS; Chevalier G; Guardiola P; Block MR; Bouvard D
J Biol Chem; 2017 Nov; 292(47):19179-19197. PubMed ID: 28972170
[TBL] [Abstract][Full Text] [Related]
13. The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex.
Gladden AB; Hebert AM; Schneeberger EE; McClatchey AI
Dev Cell; 2010 Nov; 19(5):727-39. PubMed ID: 21074722
[TBL] [Abstract][Full Text] [Related]
14. A Functional Interaction Between Na,K-ATPase β
Litan A; Li Z; Tokhtaeva E; Kelly P; Vagin O; Langhans SA
Mol Neurobiol; 2019 Nov; 56(11):7557-7571. PubMed ID: 31062247
[TBL] [Abstract][Full Text] [Related]
15. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
James MF; Han S; Polizzano C; Plotkin SR; Manning BD; Stemmer-Rachamimov AO; Gusella JF; Ramesh V
Mol Cell Biol; 2009 Aug; 29(15):4250-61. PubMed ID: 19451225
[TBL] [Abstract][Full Text] [Related]
16. Critical roles of phosphoinositides and NF2 in Hippo pathway regulation.
Hong AW; Meng Z; Plouffe SW; Lin Z; Zhang M; Guan KL
Genes Dev; 2020 Apr; 34(7-8):511-525. PubMed ID: 32115406
[TBL] [Abstract][Full Text] [Related]
17. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.
Yin F; Yu J; Zheng Y; Chen Q; Zhang N; Pan D
Cell; 2013 Sep; 154(6):1342-55. PubMed ID: 24012335
[TBL] [Abstract][Full Text] [Related]
18. Merlin in organ size control and tumorigenesis: Hippo versus EGFR?
Yi C; Kissil JL
Genes Dev; 2010 Aug; 24(16):1673-9. PubMed ID: 20713513
[TBL] [Abstract][Full Text] [Related]
19. Merlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive Pathway that Is Cell-Density Dependent and Hippo Independent.
Hikasa H; Sekido Y; Suzuki A
Cell Rep; 2016 Mar; 14(12):2950-61. PubMed ID: 26997273
[TBL] [Abstract][Full Text] [Related]
20. Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.
Ahmad Z; Brown CM; Patel AK; Ryan AF; Ongkeko R; Doherty JK
Otol Neurotol; 2010 Apr; 31(3):460-6. PubMed ID: 20195187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
